SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (420)2/16/2000 9:53:00 PM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 804
 
New coverage. Only, he is late 2 1/2 years.

Miljenko

Reuters, Feb 16, 2000 11:38 hrs

RESEARCH ALERT - Celgene (NASDAQ:CELG) initiated

NEW YORK, Feb 16 (Reuters) - JP Morgan analyst Franklin Berger said he initiated coverage of Celgene Corp. (NASDAQ:CELG) with a buy rating.

-- Further details were not immediately available.

-- Shares were up 11-3/4 at 125-1/2 on Tuesday.

Copyright 2000, Reuters News Service